Duke University Medical Center - Duke Cancer Center — Durham, North Carolina

Duke University Medical Center - Duke Cancer Center is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Duke University Medical Center - Duke Cancer Center has participated in 8 clinical trials with 4 currently active.

Therapeutic areas: Malignant PEComa, Pancreatic Ductal Adenocarcinoma, Locally Advanced Skin Squamous Cell Carcinoma.

Sponsors: Aadi Bioscience, Inc., Astellas Pharma Global Development, Inc., Rutgers, The State University of New Jersey.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Medical Center - Duke Cancer Center?

Duke University Medical Center - Duke Cancer Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Medical Center - Duke Cancer Center conducted?

Duke University Medical Center - Duke Cancer Center has 8 clinical trials on record, with 4 currently active. Their work covers Malignant PEComa, Pancreatic Ductal Adenocarcinoma, Locally Advanced Skin Squamous Cell Carcinoma.

Is Duke University Medical Center - Duke Cancer Center accredited by Crixeo Health?

Yes — Duke University Medical Center - Duke Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Duke University Medical Center - Duke Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.